Review



dce mri  (Bayer Schering Pharma)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Bayer Schering Pharma dce mri
    Dce Mri, supplied by Bayer Schering Pharma, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce+mri/pm41135295-65-1-4?v=Bayer+Schering+Pharma
    Average 86 stars, based on 1 article reviews
    dce mri - by Bioz Stars, 2026-07
    86/100 stars

    Images



    Similar Products

    ultrafast dce mri  (Philips Healthcare)
    86
    Philips Healthcare ultrafast dce mri
    Ultrafast Dce Mri, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce+mri/pm41823605-60-0-7?v=Philips+Healthcare
    Average 86 stars, based on 1 article reviews
    ultrafast dce mri - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    dce mri measurement  (Philips Healthcare)
    86
    Philips Healthcare dce mri measurement
    Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
    Dce Mri Measurement, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce+mri/pmc12913062-162-0-8?v=Philips+Healthcare
    Average 86 stars, based on 1 article reviews
    dce mri measurement - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    dce mri  (Bruker Corporation)
    97
    Bruker Corporation dce mri
    Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
    Dce Mri, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce+mri/pm41498583-406-21-25?v=Bruker+Corporation
    Average 97 stars, based on 1 article reviews
    dce mri - by Bioz Stars, 2026-07
    97/100 stars
    		  Buy from Supplier
    dce mri  (Hirschmann)
    86
    Hirschmann dce mri
    Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
    Dce Mri, supplied by Hirschmann, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce+mri/10__3390_slash_diagnostics16010136-103-20-0?v=Hirschmann
    Average 86 stars, based on 1 article reviews
    dce mri - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    dce mri  (Jiangsu Hengrui Medicine)
    86
    Jiangsu Hengrui Medicine dce mri
    Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
    Dce Mri, supplied by Jiangsu Hengrui Medicine, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce+mri/pmc12789915-71-1-8?v=Jiangsu+Hengrui+Medicine
    Average 86 stars, based on 1 article reviews
    dce mri - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    dce mri  (Bayer Schering Pharma)
    86
    Bayer Schering Pharma dce mri
    Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
    Dce Mri, supplied by Bayer Schering Pharma, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce+mri/pm41135295-65-1-4?v=Bayer+Schering+Pharma
    Average 86 stars, based on 1 article reviews
    dce mri - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    dedicated dce mri software  (Siemens Healthineers)
    86
    Siemens Healthineers dedicated dce mri software
    Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) <t>Axial</t> <t>DCE-MRI</t> image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).
    Dedicated Dce Mri Software, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dce+mri/pmc12346550-219-16-21?v=Siemens+Healthineers
    Average 86 stars, based on 1 article reviews
    dedicated dce mri software - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) Axial DCE-MRI image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).

    Journal: Frontiers in Oncology

    Article Title: A pilot study of multimodal MRI for the preoperative assessment of triple-negative breast cancer

    doi: 10.3389/fonc.2026.1714620

    Figure Lengend Snippet: Representative images of a Triple-Negative Breast Cancer (TNBC) lesion (Invasive Ductal Carcinoma, Ki-67: 60%) in the left breast. The tumor exhibits a round shape with smooth margins and heterogeneous enhancement. (A) Axial DCE-MRI image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map showing restricted diffusion. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing an outflow pattern (Type III).

    Article Snippet: DCE-MRI measurement: DCE-MRI data were processed using the Philips ISP workstation, where semi-quantitative parameters were obtained through T1-weighted perfusion analyses.

    Techniques: Diffusion-based Assay

    Representative images of a non-TNBC lesion (Luminal B subtype, Invasive Ductal Carcinoma, Ki-67: 30%) in the left breast. The tumor exhibits an irregular shape with spiculation and heterogeneous enhancement. (A) Axial DCE-MRI image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing a plateau pattern (Type II).

    Journal: Frontiers in Oncology

    Article Title: A pilot study of multimodal MRI for the preoperative assessment of triple-negative breast cancer

    doi: 10.3389/fonc.2026.1714620

    Figure Lengend Snippet: Representative images of a non-TNBC lesion (Luminal B subtype, Invasive Ductal Carcinoma, Ki-67: 30%) in the left breast. The tumor exhibits an irregular shape with spiculation and heterogeneous enhancement. (A) Axial DCE-MRI image. (B) Relative Enhancement (RE) map. (C) Maximum Enhancement (ME) map. (D) Wash-in rate (WI) map. (E) Wash-out rate (WO) map. (F) ADC map. (G) Native T1 map. (H) Enhanced T1 map. (J) T2 map. (K) Time-Intensity Curve (TIC) showing a plateau pattern (Type II).

    Article Snippet: DCE-MRI measurement: DCE-MRI data were processed using the Philips ISP workstation, where semi-quantitative parameters were obtained through T1-weighted perfusion analyses.

    Techniques:

    Receiver operating characteristic (ROC) curves evaluating the diagnostic performance of different MRI parameters and models for distinguishing TNBC from non-TNBC. (A) ROC curves of individual DCE-MRI parameters (RE, ME, WI, WO) and their combination. (B) ROC curves of quantitative mapping parameters (Enhanced T1, ΔT1%, T2) and their combination. (C) Comparison of diagnostic performance among the DCE-MRI model, Quantitative Mapping model, and the Combined Model (DCE-MRI + Quantitative Mapping). The Combined Model achieved the highest Area Under the Curve (AUC = 0.977).

    Journal: Frontiers in Oncology

    Article Title: A pilot study of multimodal MRI for the preoperative assessment of triple-negative breast cancer

    doi: 10.3389/fonc.2026.1714620

    Figure Lengend Snippet: Receiver operating characteristic (ROC) curves evaluating the diagnostic performance of different MRI parameters and models for distinguishing TNBC from non-TNBC. (A) ROC curves of individual DCE-MRI parameters (RE, ME, WI, WO) and their combination. (B) ROC curves of quantitative mapping parameters (Enhanced T1, ΔT1%, T2) and their combination. (C) Comparison of diagnostic performance among the DCE-MRI model, Quantitative Mapping model, and the Combined Model (DCE-MRI + Quantitative Mapping). The Combined Model achieved the highest Area Under the Curve (AUC = 0.977).

    Article Snippet: DCE-MRI measurement: DCE-MRI data were processed using the Philips ISP workstation, where semi-quantitative parameters were obtained through T1-weighted perfusion analyses.

    Techniques: Diagnostic Assay, Comparison